AR109807A1 - Sistema de suministro transdérmico de pramipexol y usos del mismo - Google Patents
Sistema de suministro transdérmico de pramipexol y usos del mismoInfo
- Publication number
- AR109807A1 AR109807A1 ARP170102776A ARP170102776A AR109807A1 AR 109807 A1 AR109807 A1 AR 109807A1 AR P170102776 A ARP170102776 A AR P170102776A AR P170102776 A ARP170102776 A AR P170102776A AR 109807 A1 AR109807 A1 AR 109807A1
- Authority
- AR
- Argentina
- Prior art keywords
- pramipexol
- same
- polymers
- supply system
- drug
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Medical Informatics (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Reivindicación 1: Un parche transdérmico para tratar la enfermedad de Parkinson, que comprende: (i) una capa que contiene fármaco; (ii) una capa de refuerzo; y (iii) una capa protectora, en donde la capa que contiene fármaco comprende pramipexol o una sal farmacéuticamente aceptable del mismo y dos o más polímeros, en donde por lo menos dos de los polímeros comprenden cada uno un grupo funcional carboxilo y/o un grupo funcional hidroxilo. Reivindicación 4: El parche transdérmico de conformidad con la reivindicación 1, caracterizado además porque los por lo menos dos polímeros cada uno comprende un polímero a base de acrilato.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2016/055866 WO2018067163A1 (en) | 2016-10-07 | 2016-10-07 | Pramipexole transdermal delivery system and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AR109807A1 true AR109807A1 (es) | 2019-01-23 |
Family
ID=61830567
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170102776A AR109807A1 (es) | 2016-10-07 | 2017-10-05 | Sistema de suministro transdérmico de pramipexol y usos del mismo |
Country Status (8)
Country | Link |
---|---|
US (2) | US10729679B2 (es) |
EP (1) | EP3522843B1 (es) |
JP (1) | JP6978417B2 (es) |
KR (1) | KR20190065184A (es) |
CN (3) | CN109310526B (es) |
AR (1) | AR109807A1 (es) |
CA (1) | CA3003460A1 (es) |
WO (1) | WO2018067163A1 (es) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US330922A (en) * | 1885-11-24 | Music-rack and walking-cane combined | ||
US5008110A (en) * | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
DE3937271A1 (de) * | 1989-11-09 | 1991-05-16 | Boehringer Ingelheim Kg | Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol |
US20030170195A1 (en) * | 2000-01-10 | 2003-09-11 | Noven Pharmaceuticals, Inc. | Compositions and methods for drug delivery |
US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
DE10137082A1 (de) * | 2001-07-28 | 2003-02-13 | Hexal Ag | Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol |
AR040682A1 (es) * | 2002-07-25 | 2005-04-13 | Pharmacia Corp | Forma de dosificacion una vez al dia de pramipexol |
DE10333393A1 (de) * | 2003-07-23 | 2005-02-24 | Lts Lohmann Therapie-Systeme Ag | Transdermales Therapeutisches System mit dem Wirkstoff Pramipexol |
DE10338174A1 (de) * | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
CA2542778C (en) * | 2003-10-28 | 2012-05-29 | Noven Pharmaceuticals, Inc. | Transdermal drug delivery composition |
WO2006041907A2 (en) * | 2004-10-08 | 2006-04-20 | Noven Pharmaceuticals, Inc. | Transdermal delivery of estradiol |
CN101147739B (zh) | 2007-07-06 | 2010-12-08 | 北京康倍得医药技术开发有限公司 | 含罗替戈汀的组合物及其制药用途以及含该组合物的透皮贴剂 |
DE102012205493A1 (de) * | 2012-04-03 | 2013-10-10 | Acino Ag | Einen Dopamin-Agonisten enthaltendes transdermales Applikationssystem |
US9682068B2 (en) * | 2013-05-20 | 2017-06-20 | Mylan Inc. | Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders |
CN103432104B (zh) * | 2013-08-09 | 2015-10-28 | 大连理工大学 | 一种含有普拉克索的透皮贴剂 |
CN103610666A (zh) | 2013-12-11 | 2014-03-05 | 中国药科大学 | 一种盐酸普拉克索透皮贴剂及其制备方法 |
EP3067050A1 (en) * | 2015-03-13 | 2016-09-14 | Acino AG | Transdermal therapeutic system with an overtape comprising two adhesive layers |
-
2016
- 2016-10-07 WO PCT/US2016/055866 patent/WO2018067163A1/en unknown
- 2016-10-07 CN CN201680084423.3A patent/CN109310526B/zh active Active
- 2016-10-07 JP JP2018529579A patent/JP6978417B2/ja active Active
- 2016-10-07 CN CN202210484939.4A patent/CN114668747A/zh active Pending
- 2016-10-07 EP EP16918441.3A patent/EP3522843B1/en active Active
- 2016-10-07 CA CA3003460A patent/CA3003460A1/en active Pending
- 2016-10-07 KR KR1020187022840A patent/KR20190065184A/ko not_active Application Discontinuation
- 2016-10-07 CN CN202210485428.4A patent/CN114796163A/zh active Pending
- 2016-12-19 US US15/384,286 patent/US10729679B2/en active Active
-
2017
- 2017-10-05 AR ARP170102776A patent/AR109807A1/es unknown
-
2020
- 2020-06-12 US US16/900,140 patent/US11291656B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN109310526A (zh) | 2019-02-05 |
EP3522843A4 (en) | 2020-04-29 |
US20200368209A1 (en) | 2020-11-26 |
CN109310526B (zh) | 2022-05-17 |
EP3522843A1 (en) | 2019-08-14 |
CN114668747A (zh) | 2022-06-28 |
US10729679B2 (en) | 2020-08-04 |
JP2019529332A (ja) | 2019-10-17 |
KR20190065184A (ko) | 2019-06-11 |
CA3003460A1 (en) | 2018-04-12 |
WO2018067163A1 (en) | 2018-04-12 |
EP3522843B1 (en) | 2022-09-21 |
US11291656B2 (en) | 2022-04-05 |
CN114796163A (zh) | 2022-07-29 |
US20180098973A1 (en) | 2018-04-12 |
JP6978417B2 (ja) | 2021-12-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120783T1 (el) | Ανθεκτικη εναντι παραβιασης και ανθεκτικη εναντι μεταποθηκευσης δοσης φαρμακευτικη μορφη δοσολογιας | |
CL2016002753A1 (es) | Composición conservante de la madera | |
PE20160002A1 (es) | Sistema de liberacion transdermico | |
ECSP18073366A (es) | Derivados de indolina sustituidos como inhibidores de la replicación vírica de dengue | |
BR112018015273A2 (pt) | derivados de benzimidazol como moduladores de ror-gama | |
BR112018077021A2 (pt) | terapias de combinação | |
BR112014014137A2 (pt) | sistema de liberação transdérmica compreendendo buprenorfina | |
BR112017006299A2 (pt) | derivados indol mono- ou dissubstituídos como inibidores da replicação viral da dengue | |
BR112018068956A2 (pt) | derivados do composto indol substituídos como inibidores da replicação viral da dengue | |
BR112017025108A2 (pt) | compostos seletivos de pyy e usos dos mesmos | |
BR112017019738A2 (pt) | macrociclos peptidomiméticos e usos dos mesmos | |
CL2017001822A1 (es) | Derivados de indol mono o disustituido como inhibidores de la replicación del virus del dengue | |
BR112017005598A2 (pt) | macrociclos peptidomiméticos e usos dos mesmos | |
CO2018009559A2 (es) | Derivados de indol sustituidos como inhibidores de la replicación vírica del dengue | |
UY36339A (es) | Indoles mono o disustituidos como inhibidores de la replicación del virus del dengue | |
BR112015024271A2 (pt) | sistema de fornecimento transdérmico | |
BR112015020139A2 (pt) | compostos terapêuticos e usos dos mesmos | |
BR112018075703A2 (pt) | microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade | |
EA201790721A1 (ru) | Инъекционный состав бупренорфина | |
CL2015002847A1 (es) | Sistemas y métodos para tratar una respuesta farmacodinámica adversa inducida por opioides (divisional de la solicitud n° 0110-2015). | |
BR112019024322A2 (pt) | Compostos e composições terapêuticos e métodos de uso dos mesmos | |
AR100369A1 (es) | Composición de dosis fija de formoterol y budesonide | |
AR108500A1 (es) | Un análogo de trifluoroetil quinolina específico para usar en el tratamiento de apds | |
BR112019000897A2 (pt) | sal de adição de ácido, composição farmacêutica, uso do sal de adição de ácido ou da composição farmacêutica, e, método para prevenção, tratamento ou atenuação de um distúrbio de fibrose de tecido ou órgão. | |
BR112017005416A2 (pt) | composição farmacológica de tratamento e prevenção de doenças neurológicas degenerativas contendo como ingrediente ativo extrato de mistura de casca da raiz de peônia da montanha, raiz de angelica dahurica e raiz de bupleurum ou fragmentos dos mesmos |